A Phase 2 Study of IPI-145 in Subjects with Refractory Indolent Non-Hodgkin Lymphoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 2 Study of IPI-145 in Subjects with Refractory Indolent Non-Hodgkin Lymphoma

Type of Cancer
Lymphoma
Locations
Howell
Sponsor
Infinity
Protocol Number
IPI-145-06
Cancer Diagnosis
To Learn More Call
201-510-0910